Effects of cytokines on the liver

Hepatology

Volumn 13, Issue 2, 1991, Pages 364-375

  Andus, Tilo ^a   Bauer, Joachim ^b   Gerok, Wolfgang ^a  

^a Abteilung für Endokrinologie   (Germany)

^b UNIVERSITY OF FREIBURG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; EPIDERMAL GROWTH FACTOR; GROWTH FACTOR; INTERFERON; INTERLEUKIN 1; INTERLEUKIN 6; TUMOR NECROSIS FACTOR;

CARBOHYDRATE METABOLISM; FIBROSIS; HUMAN; LIPID METABOLISM; LIVER CIRRHOSIS; LIVER METABOLISM; PRIORITY JOURNAL; PROTEIN SYNTHESIS; REVIEW;

ANIMAL; CARBOHYDRATES; CYTOKINES; HUMAN; LIPIDS; LIVER; PROTEINS;

EID: 0026021473     PISSN: 02709139     EISSN: 15273350     Source Type: Journal    
DOI: 10.1002/hep.1840130226     Document Type: Article

References (233)

1. Peptide regulatory factors: multifunctional mediators of cellular growth and differentiation
2. The cytokine network
3. Nutritional aspects of leukocytic cytokines
4. Interleukins and the immune system 1
5. Interleukins and the immune system 2
6. Interleukin‐1 and its biologically related cytokines
7. Interleukin 1: the first interleukin
8. The role of interleukin 2 in autoimmunity
9. The biology of interleukin‐6
10. Interleukin‐6 and its receptor during homeostasis, inflammation, and tumor growth
11. Interleukin‐6, a key hormone of the acute phase reaction
12. Interleukin‐6 and the acute phase response
13. The biology of cachectin/TNF: a primary mediator of the host response
14. Cachectin/tumour necrosis factor
15. Molecular cloning and expression of the human homologue of the murine gene encoding myeloid leukemiainhibitory factor
16. Interaction of interferon with other cytokines
17. Interferons
18. Epidermal growth factor and related molecules
19. Biological effects of epidermal growth factor, with emphasis on the gastrointestinal tract and liver: an update
20. Transforming growth factor α
21. Inflammatory and immunomodulatory roles of TGF‐β
22. The heparin‐binding (fibroblast) growth factor family of proteins
23. Peptide regulatory factors in the nervous system
24. Platelet‐derived growth factor
25. Insulin‐like growth factors I and II: peptide, messenger ribonucleic acid and gene structures, serum, and tissue concentrations
26. Temperature and metabolic changes in rats after various doses of tumour necrosis factor α
27. Comparative effects of tumour necrosis factor‐α (cachectin), interleukin‐1‐beta and tumour growth on amino acid metabolism in the rat in vivo: absorption and tissue uptake of α‐amino[1‐14C]isobutyrate
28. Modulation of endogeneous hormone action by recombinant human tumor necrosis factor
29. The effects of tumor necrosis factor α (cachectin) and tumor growth on hepatic amino acid utilization in the rat
30. Stimulatory effect of interleukin‐1 upon hepatic metabolism
31. Different preparations of natural and recombinant human interleukin‐6 (IFN‐β2, BSF‐2) similarly stimulate acute phase protein synthesis and uptake of α‐aminoisobutyric acid by cultured rat hepatocytes
32. Epidermal growth factor, like glucagon, exerts a short‐term stimulation of alanine transport in rat hepatocytes
33. Transforming growth factor‐β and epidermal growth factor modulate basal and interleukin‐6‐induced amino acid uptake and acute phase protein synthesis in cultured rat hepatocytes
34. EGF inhibits glucagon stimulation of amino acid transport in primary cultures of adult rat hepatocytes
35. Acute effects of insulin‐like growth factor I on glucose and amino acid metabolism in the awake fasted rat: comparison with insulin
36. Identification of some interleukin‐1 (IL‐1) sensitive organs in vivo using the induction of ornithine decarboxylase (ODC) following injection of recombinant IL‐1 beta in mice
37. Induction of histidine and ornithine decarboxylase activities in mouse tissues by recombinant interleukin‐1 and tumor necrosis factor
38. Epidermal growth factor IV: the induction of ornithin decarboxylase
39. Epidermal growth factor stimulation of ornithin decarboxylase activity in a human hepatoma cell line
40. Epidermal growth factor as a new regulator of induction of tyrosine aminotransferase and tryptophan oxygenase by glucocorticoids
41. Current concepts of protein turnover and amino acid transport in liver and skeletal muscle during sepsis
42. Acute phase protein with special reference to C‐reactive protein and related proteins (Pentains) and serum amyloid A protein
43. The phenomenon of the acute phase response
44. Induction of rat acute‐phase proteins by interleukin‐6 in vivo
45. Interleukin‐6, the third mediator of acute‐phase reaction, modulates hepatic protein synthesis in human and mouse: comparison with interleukin‐1β and tumor necrosis factor α
46. IL‐6 modulates the synthesis of a specific set of acute phase plasma proteins in vivo
47. Pretranslational modulation of acute phase hepatic protein synthesis by murine recombinant interleukin‐1
48. Fate and biological action of human recombinant interleukin‐1β in the rat in vivo
49. Changes in rat liver mRNA for α‐1‐acid‐glycoprotein, apolipoprotein E, apolipoprotein B and beta‐actin after mouse recombinant tumor necrosis factor injection
50. Recombinant human interleukin‐6 (IL‐6/BSF‐2/HSF) regulates the synthesis of acute phase proteins in human hepatocytes
51. The effect of interleukin‐1, interleukin‐6 and its interrelationship on the synthesis of serum amyloid A and C‐reactive protein in primary cultures of adult human hepatocytes
52. Interleukin‐6 is the major regulator of acute phase protein synthesis in adult human hepatocytes
53. Interferon beta 2/B‐cell stimulatory factor type 2 shares identity with monocyte‐derived hepatocyte‐stimulating factor and regulates the major acute phase protein response in liver cells
54. Regulation of synthesis and secretion of major rat acute‐phase proteins by recombinant human interleukin‐6 in hepatocyte primary cultures
55. Cachectin/tumor necrosis factor regulates hepatic acute‐phase gene expression
56. Interferon β2/B‐cell stimulating factor 2/interleukin 6 affects glycosylation of acute phase proteins in human hepatoma cell lines
57. The synthesis of human α‐2‐HS‐glycoprotein is downregulated by cytokines in hepatoma HepG2 cells
58. Heterogeneous nature of the acute phase response: differential regulation of human serum amyloid A, C‐reactive protein and other acute phase proteins by cytokines in Hep 3B cells
59. Monocyte conditioned medium, interleukin‐1, and tumor necrosis factor stimulate the acute phase response in human hepatoma cells in vitro
60. Role of interleukin‐6 in regulating synthesis of C‐reactive protein and serum amyloid A in human hepatoma cell lines
61. Effect of cytokines on glycosylation of acute phase proteins in human hepatoma cell lines
62. Recombinant human B cell stimulatory factor 2 (BSF‐1/IFN‐β2) regulates β‐fibrinogen and albumin mRNA levels in Fao‐9 cells
63. Action of recombinant interleukin‐6, interleukin‐1β and tumor necrosis factor α on the mRNA induction of acute‐phase proteins
64. 1‐acid glycoprotein by recombinant human interleukin 1 in rat hepatoma cells
65. Distinct sets of acute phase plasma proteins are stimulated by separate human hepatocyte‐stimulating factors and monokines in rat hepatoma cells
66. Synthesis of hemopexin and cysteine proteinase inhibitor is coordinately regulated by HSF‐II and interferon β2 in rat hepatoma cells
67. Monokines regulate glycosylation of acute‐phase proteins
68. Human hepatocytestimulating factor‐III, and interleukin‐6 are structurally and immunologically distinct but regulate the production of the same acute phase plasma proteins
69. Hepatocyte‐stimulating factor III shares structural and functional identity with leukemia‐inhibitory factor
70. Synthesis and regulation of the two human complement C4 genes in stable transfected mouse fibroblasts
71. Inhibitory effect of human recombinant interferon gamma on synthesis of acute phase proteins in human hepatoma HepG2 cells stimulated by leukocyte cytokines, TNF α and IFN‐β2/BSF‐2/IL‐6
72. Post‐transcriptional control of negative acute phase genes by transforming growth factor beta
73. Transforming growth factor β1 regulates production of acute‐phase proteins
74. Phorbol ester modulates interleukin 6‐ and interleukin 1‐regulated expression of acute phase plasma proteins in hepatoma cells
75. Studies on the structure and regulation of the human hepatic interleukin‐6‐receptor
76. Fate of interleukin‐6 in the rat: involvement of skin in its catabolism
77. cDNA expression cloning of the IL‐1 receptor, a member of the immunoglobulin superfamily
78. Cloning and expression of the human interleukin‐6 (BSF‐2/IFNβ2) receptor
79. Molecular cloning and expression of the human 55kD tumor necrosis factor receptor
80. Molecular cloning and expression of a receptor for human tumor necrosis factor
81. Complementary DNA cloning of a receptor for tumor necrosis factor and demonstration of a shed form of the receptor
82. A receptor for tumor necrosis factor defines an unusual family of cellular and viral proteins
83. A new cytokine receptor superfamily
84. Interleukin‐6 triggers the association of its receptor with a possible signal transducer, gp130
85. Divergent activities of protein kinases in IL‐6‐induced differentiation of a human B cell line
86. IL‐1 activates two separate signal transduction pathways in T helper type II cells
87. Interleukin‐1 signal transduction
88. IL‐1 induces rabbit phosphorylation of the IL‐1 receptor
89. IL‐1 and its receptor are translocated to the nucleus
90. Tumor necrosis factor α induces the phosphorylation of 28kD stress proteins in endothelial cells: possible role in protection against cytotoxicity
91. Tumor necrosis factor α modifies agonist‐dependent responses in human neutrophil by inducing the synthesis and myristoylation of a specific protein kinase C substrate
92. Hepatocyte‐stimulating factor, β2 interferon, and interleukin‐1 enhance expression of the rat α1‐acid glycoprotein gene via a distal upstream regulatory region
93. Recombinant interleukin 6 regulates the transcriptional activation of a set of human acute phase genes
94. 2‐macroglobulin gene
95. 2‐macroglobulin gene
96. Interleukin 6 induces a liver‐specific nuclear protein that binds to the promoter of acute‐phase genes
97. The human haptoglobin gene promoter: interleukin‐6‐responsive elements interact with a DNA‐binding protein induced by interleukin‐6
98. Dual control of C‐reactive protein gene expression by interleukin‐1 and interleukin‐6
99. 2‐macroglobulin gene
100. cis‐Acting elements responsible for interleukin‐6 inducible C‐reactive protein gene expression
101. Constitutive and IL‐6‐induced nuclear factors that interact with the human C‐reactive protein promoter
102. Structure, hormonal regulation, and identification of the interleukin‐6‐ and dexamethasoneresponsive element of the rat haptoglobin gene
103. 1‐inhibitor III gene is controlled by a novel combination of cis‐acting regulatory elements
104. Regulation of mouse serum amyloid A gene expression in transfected hepatoma cells
105. 2‐macroglobulin gene
106. 1‐acid glycoprotein gene is a complex of several interacting regulatory sequences
107. Tumor necrosis factor‐α induces a kappa B sequence‐specific DNA‐binding protein in human hepatoblastoma HepG2 cells
108. Regulation of hepatocyte gene expression: progress on the horizon [Editorial]
109. Interleukin‐1 and cyclic AMP induce kappa immunoglobulin light chain expression via activation of an NFkB‐like DNA‐binding protein
110. Identification of cis‐acting sequences responsible for phorbol ester induction of human serum amyloid A gene expression via a nuclear kB‐like transcription factor
111. An inducible 50‐kilodalton NFkB‐like protein and a constitutive protein both bind the acute‐phase response element of the angiotensinogen gene
112. The permissive role of glucocorticoids on interleukin‐1 stimulation of angiotensinogen gene transcription is mediated by an interaction between inducible enhancers
113. Prolonged activation of jun and collagenase genes by tumor necrosis factor‐α
114. 2‐macroglobulin in rat hepatocyte primary cultures: action of a hepatocytestimulating factor, triiodothyronine and dexamethasone
115. 2‐macroglobulin in vivo and in hepatocyte primary cultures: synergistic action of glucocorticoids and a Kupffer cell derived factor
116. Regulation of interleukin‐6 receptor expression in human monocytes and hepatocytes
117. Regulation of interleukin 6 receptor expression in human monocytes and monocyte‐derived macrophages: comparison with the expression in human hepatocytes
118. Plasma clearance, organ distribution and target cells of interleukin‐6/hepatocyte stimulating factor in the rat
119. Soluble cytokine receptors are present in normal human urine
120. 2‐macroglobulin
121. Native interleukin 1 inhibitors
122. Two tumor necrosis factor–binding proteins purified from human urine: evidence for immunological cross‐reactivity with cell surface tumor necrosis factor receptors
123. Characterization of a tumor necrosis factor α (TNF‐α) inhibitor: evidence of immunological cross‐reactivity with the TNF receptor
124. Effect of inflammatory agents and interleukin 1 on iron and zinc metabolism
125. Temperature and metabolic changes in rats after various doses of tumour necrosis factor α
126. Interleukin‐1 regulates human metallothioneine expression
127. Interleukin 6 regulates metallothioneine gene expression and zinc metabolism in hepatocyte monolayer cultures
128. Tissue‐specific regulation of zinc metabolism and metallothionein genes by interleukin 1
129. Tumor necrosis factor‐α stimulates hepatic lipogenesis in the rat in vivo
130. Tumor necrosis factor stimulates hepatic lipid synthesis and secretion
131. Mechanism of the hypertriglyceridemia induced by tumor necrosis factor administration to rats
132. Multiple cytokines stimulate hepatic lipid synthesis in vivo
133. Mechanisms by which tumor necrosis factor stimulates hepatic fatty acid synthesis in vivo
134. Multiple effects of tumor necrosis factor on lipoprotein lipase in vivo
135. Tissue‐specific regulation of guinea pig lipoprotein lipase: effects of nutritional state and of tumor necrosis factor on mRNA levels in adipose tissue, heart and liver
136. Acute effects of insulin‐like growth factor I on glucose and amino acid metabolism in the awake fasted rat: comparison with insulin
137. Interleukin 6 stimulates hepatic glucose release from prelabeled glycogen pools
138. Epidermal‐growth‐factor stimulation of gluconeogenesis in isolated rat hepatocytes involves the inactivation of pyruvate kinase
139. The effects of recombinant tumour necrosis factor (cachectin) on metabolism in isolated rat adipocyte, hepatocyte and muscle preparations
140. Interleukin 1: a regulatory role in glucocorticoid‐regulated hepatic metabolism
141. Epidermal growth factor stimulates glycogen synthesis in fetal rat hepatocytes: comparison with the glycogenic effects of insulin‐like growth factor I and insulin
142. Insulin‐like growth factors (IGF I and IGF II) mimic the effect of insulin on plasma protein synthesis and glycogen deposition in cultured hepatocytes
143. Epidermal growth factor counteracts the glycogenic effect of insulin in parenchymal hepatocyte cultures
144. Epidermal growth factor mimics insulin effects in rat hepatocytes
145. Sex difference in epidermal growth factor receptor levels in rat liver plasma membrane
146. Reversal of the toxic effects of cachectin by concurrent insulin administration
147. Recombinant tumor necrosis factor depresses cytochrome P450–dependent microsomal drug metabolism in mice
148. Rat but not human interferons suppress hepatic oxidative drug metabolism in rats
149. Dexamethasone modulation of in vivo effects of endotoxin, tumor necrosis factor, and interleukin‐1 on liver cytochrome P450, plasma fibrinogen, and serum iron
150. Lymphokines and bile secretion in the rat
151. Effect of epidermal growth factor on growth and postnatal development of the rabbit liver
152. Ontogenesis of epidermal growth factor in liver of BALB mice
153. Developmental regulation of insulin‐like growth factor II mRNA in different rat tissues
154. Heparin‐binding growth factor type 1 (acidic fibroblast growth factor): a potential biphasic autocrine and paracrine regulator of hepatocyte regeneration
155. Transforming growth factor α may be a physiological regulator of liver regeneration by means of an autocrine mechanism
156. Tissue distribution of insulin‐like growth factor I and II messenger ribonucleic acid in the adult rat
157. Anemia induces accumulation of erythropoietin mRNA in the kidney and liver
158. Immunolocalization of α interferon in liver disease
159. Demonstration of a basic fibroblast growth factor–like molecule in mouse hepatic endothelial cells
160. Cellular distribution of transforming growth factor‐β1 and procollagen types I, III, and IV transcripts in carbon tetrachloride–induced rat liver fibrosis
161. Spontaneous production of tumor necrosis factor α by Kupffer cells of MRL/lpr mice
162. Virus versus endotoxin‐induced activation of liver macrophages
163. Interleukin‐6 release by rat liver macrophages
164. Biologically active products of stimulated liver macrophages (Kupffer cells)
165. Fate and biological action of human recombinant interleukin 1 beta in the rat in vivo
166. Tissue localization and fate in mice of injected multipotential colony‐stimulating factor
167. Cellular targets and receptors for interleukin‐6. I. In vivo and in vitro uptake of IL‐6 in liver and hepatocytes
168. Pharmacokinetics and tissue distribution of recombinant human tumor necrosis factor‐α in mice
169. Hepatic processing of transforming growth factor beta in the rat: uptake, metabolism, and biliary excretion
170. From old results to new perspectives: a look at interferon's fate in the body
171. Hepatic sequestration and biliary secretion of epidermal growth factor: evidence for a high‐capacity uptake system
172. Distribution of epidermal growth factor binding sites in the adult rat liver
173. Kinetic analysis of the elimination process of human epidermal growth factor (hEGF) in rats
174. Translocation of epidermal growth factor to the hepatocyte nucleus during rat liver regeneration
175. Transport of epidermal growth factor by rat liver: evidence of a nonlysosomal pathway
176. The fate and uptake of murine epidermal growth factor in the sheep
177. Immunofluorescent localization of type II insulin‐like growth factor receptor in rat liver and hepatoma cells
178. Heterogeneous lobular distribution of hepatocytes expressing acute‐phase genes during the acute inflammatory reaction
179. Peptide regulatory factors in embryonic development
180. Influence of epidermal growth factor on liver regeneration after partial hepatectomy in rats
181. Arrest of epidermal growth factor–dependent growth in fetal hepatocytes after ethanol exposure
182. Regulation of the proliferation of primary rat hepatocytes by eicosanoids
183. Growth hormone enhances hepatic epidermal growth factor receptor concentration in mice
184. Sex difference in epidermal growth factor receptor levels in rat liver plasma membrane
185. Plasma growth hormone pattern regulates epidermal growth factor (EGF) receptor messenger ribonucleic acid levels and EGF binding in the rat liver
186. Different response to epidermal growth factor of hepatocytes in cultures isolated from male or female rat liver: inhibitor effect of estrogen on binding and mitogenic effect of epidermal growth factor
187. Dexamethasone–induced changes in phosphorylation of the insulin and epidermal growth factor receptors and their sub‐strates in intact rat hepatocytes
188. Transforming growth factor‐α stimulates proto‐oncogene c‐jun expression and a mitogenic program in primary cultures of adult rat hepatocytes
189. Transforming growth factor receptors in liver regeneration following partial hepatectomy in the rat
190. Expression of hepatic transforming growth factor receptors during late gestation in the fetal rat
191. Inhibition of proliferation of normal, preneoplastic, and neoplastic rat hepatocytes by transforming growth factor‐beta
192. Inhibition of DNA synthesis in rat hepatocytes by platelet‐derived type beta transforming growth factor
193. Transforming growth factor beta inhibits DNA synthesis in hepatocytes isolated from normal and regenerating rat liver
194. Type beta transforming growth factor reversibly inhibits the early proliferative response to partial hepatectomy in the rat
195. Transforming growth factor beta mRNA increases during liver regeneration: a possible paracrine mechanism of growth regulation
196. Characterization of a Mr 25,000 basic fibroblast growth factor form in adult, regenerating, and fetal rat liver
197. Molecular cloning and sequence analysis of cDNA for human hepatocyte growth factor
198. Molecular cloning and expression of human hepatocyte growth factor
199. Purification and characterization of a growth factor from rat platelets for mature parenchymal hepatocytes in primary cultures
200. Tumor necrosis factor stimulates DNA synthesis in the liver of intact rats
201. Interleukin‐1 beta is a potent growth inhibitor of adult rat hepatocytes in primary culture
202. Effect of human recombinant interleukin‐6 on the proliferation of mouse hepatocytes in the primary culture
203. Depressed liver regeneration after partial hepatectomy of germ‐free, athymic and lipopolysaccharide‐resistant mice
204. Cellular immunity and hepatitis associated (Australia) antigen liver disease
205. Cellular localization of α‐interferon in hepatitis B virus–infected liver tissue
206. Absence of detectable serum interferon in acute and chronic viral hepatitis
207. Interferon production by peripheral lymphocytes in HBsAg‐positive liver diseases
208. Lack of in vivo activation of the interferon system of HBsAg‐positive chronic active hepatitis
209. Evidence for a deficiency of interferon production in patients with chronic hepatitis B virus infection acquired in adult life
210. Transcription of the human beta interferon gene is inhibited by hepatitis B virus
211. Defective response to interferons in cells transfected with the hepatitis B virus genome
212. Elevated HLA class I antigen expression on peripheral blood mononuclear cells of HBsAg carriers with coexistent human immunodeficiency virus infection
213. In vitro effects of lymphoblastoid interferon on lymphocyte activation and cell‐mediated cytolysis in patients with chronic hepatitis B virus infection
214. Soluble interleukin 2 receptor in acute viral hepatitis and chronic liver disease
215. Interleukin‐1 and interleukin‐2 activity in chronic hepatitis B virus infection
216. Interleukins in chronic active hepatitis B: relationship with viral markers
217. Preferential activation of helper/inducer T lymphocytes in autoimmune chronic active hepatitis
218. Expression of the genes of interferons and other cytokines in normal and diseased tissues of man
219. In vitro and in vivo association of transforming growth factor‐beta 1 with hepatic fibrosis
220. Effect of epidermal growth factor on collagen formation in liver‐derived epithelial clone cells
221. Cellular fibronectin is induced by epidermal growth factor, but not by dexamethasone or cyclic AMP in rat liver epithelial cells
222. Effects of platelet‐derived growth factor and other polypeptide mitogens on DNA synthesis and growth of cultured rat liver fat‐storing cells
223. Differential effects of interleukin‐1 α, tumor necrosis factor α, and transforming growth factor beta 1 on cell proliferation and collagen formation by cultured fat‐storing cells
224. Stimulation of hepatic lipocyte collagen production by Kupffer cell–derived transforming growth factor β: implication for a pathogenetic role in alcoholic liver fibrogenesis
225. Transforming growth factor beta responsiveness is modulated by the extracellular collagen matrix during hepatic Ito cell culture
226. Liver fat storing cell proliferation is stimulated by epidermal growth factor/transforming growth factor α and inhibited by transforming growth factor beta
227. Ito‐cell gene expression and collagen regulation
228. Transforming growth factor beta modulates the expression of collagenase and metalloproteinase inhibitor
229. Regulation of TGFβ gene expression in rat liver intoxicated with carbon tetrachloride